Spectrum Pharmaceuticals, Inc (NASDAQ:SPPI) has lately been going through difficult times. The most tragic point was when the biopharma pronounced the failure of the drugs in the Phase II trial. These had been targeted towards the treatment of very severe lung cancer. The test confirmed that the drug did not meet the required endpoint, something […]
Sign Up To Get Our Instant Alerts!
- Japanese Premier Declares COVID-19 State of Emergency in Tokyo 55 views
- Expect Even More Unique Electric Cars Says Ferrari 39 views
- 4CABLE TV INTERNATIONAL, INC. ANNOUNCES SETTLEMENT OF THE MARQUIS TRADING DEBT, OPENING OF THE FIRST OF ITS KIND HIP RESTAURANT AND THE UNDERGOING OF REPAIRS AT THE CIGN FARM 38 views
- BT and Ericsson Partners to Build Private 5G Networks 29 views
- U.S Resumes Talks With Embattled Huawei CFO Meng Wanzhou 26 views